LCTX

#3104
Lineage Cell Therapeutics, Inc.
1.5900 USD
+6.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
1.5750
1.5900
Rango anual
1.4200
1.9850
Cambio diario
+6.00%
Variación mensual
+1.27%
Variación en los últimos 6 meses
-7.40%
Cambio anual
-7.40%
Cierres anteriores
1.5000
Abrir
1.5750
Bid
Ask
Mínimo
1.5750
High
1.5900
Volumen
240
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 396.0492 M
  • Employee 77
  • Founded 1990
  • CEO N/A
  • Website www.lineagecell.com
  • Headquarter California, United States
  • FIGI BBG000G8RJY6
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.96
Relación precio/flujo de caja
26.4

Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer.

Noticias